Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Carl Zeiss Meditec is a German medical technology company focused on ophthalmology and microsurgery, which represent about three-quarters and one-quarter of its revenue, respectively. Carl Zeiss has...
— Brown Capital Management International All Company Fund
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Carl Zeiss Meditec
More institutional theses from Brown Capital Management International All Company Fund
The manager discusses shareholder activism at Abcam that led management to launch a full strategic review of alternatives, including a potential sale. The ongoing governance...
The manager is highly positive on RELX's subscription-heavy model and its proactive adoption of generative AI through Lexis+ AI. By training large...
The manager initiated a new position in the company to capture the large structural opportunity in advanced driver assisted systems and autonomous driving. Despite showing short-term...